Introduction
============

Meningiomas are common intracranial tumors that account for \~36% of all primary central nervous system tumors ([@b1-ol-0-0-8376]). According to the World Health Organization classification ([@b2-ol-0-0-8376]), meningiomas may be divided into three grades, including benign (Grade I), atypical (Grade II) and anaplastic (Grade III) meningiomas. Although the majority of meningiomas are benign tumors that are curable by surgery, atypical and anaplastic tumors remain therapeutically challenging due to the high risk of tumor relapse ([@b3-ol-0-0-8376],[@b4-ol-0-0-8376]). Furthermore, even after complete resection, relapse occurs in \>5% of benign meningiomas ([@b5-ol-0-0-8376],[@b6-ol-0-0-8376]).

The pathogenesis of meningioma is a complex process associated with an accumulation of various genetic and epigenetic alterations that occur during the initiation and progression of the tumor ([@b7-ol-0-0-8376]). Monosomy 22, 22q deletion and/or mutation of the neurofibromatosis type 2 gene have been identified as important initiating events and represent the most common genetic alterations in meningiomas ([@b8-ol-0-0-8376]--[@b10-ol-0-0-8376]). Other common chromosomal alterations include deletions of 1p, 6q, 10q and 14q, and insertions of 1q, 9q, 12q, 15q, 17q and 20q ([@b7-ol-0-0-8376],[@b11-ol-0-0-8376],[@b12-ol-0-0-8376]). However, there is insufficient evidence to verify the capability of these chromosomal alterations to predict tumor recurrence and progression.

Several gene expression profiling studies have been conducted on meningiomas, and several candidate genes have been proposed as recurrence-associated predictors or progression-associated biomarkers of meningiomas among the differentially expressed genes (DEGs), including KLF4, GAB2, TRAF7, LMO3, SMO and TSLC1 ([@b13-ol-0-0-8376]--[@b16-ol-0-0-8376]). Additionally, the prognostic capabilities of CKS2, PTTG1 and the leptin receptor have also been indicated by mixed transcriptome analyses ([@b17-ol-0-0-8376],[@b18-ol-0-0-8376]). However, research has mainly focused on identifying candidate genes that may be potential novel biomarkers for meningioma, while the possible intrinsic links among DEGs have not been extensively investigated. Studies aimed at identifying the key pathways and characteristics of the biology involved in this tumor remain limited ([@b11-ol-0-0-8376],[@b14-ol-0-0-8376],[@b17-ol-0-0-8376],[@b18-ol-0-0-8376]).

Traditional biology research can reveal molecular mechanisms based on the variation and function of an individual gene, mRNA or protein; however, it only describes the biological phenomenon of a disease from a partial viewpoint, rather than describing it in the context of the entire system. Bioinformatics analysis is a powerful tool that provides a novel platform to study the characteristics of biology at a more holistic perspective and elaborate the association of different functional elements ([@b7-ol-0-0-8376],[@b15-ol-0-0-8376],[@b18-ol-0-0-8376]).

In the present study, bioinformatics analysis was conducted to determine several potential biomarkers of meningioma (namely JUN, PIK3R1, FOS, AGT and MYC), as well as to identify relevant pathways (including the AGE-RAGE signaling pathway in diabetic complications, PI3K-Akt signaling pathway, ECM-receptor interaction and cell adhesion among others), which are potentially involved in the onset and progression of meningioma. Furthermore, clinical evidence exists to verify the capability of these aforementioned biomarkers and pathways in the prediction of meningioma recurrence and progression. In conclusion, the findings of the present study provide further insight into the pathogenesis of meningiomas and provide potential therapeutic targets for further studies.

Materials and methods
=====================

### Source of data

Initially, the microarray expression profile of the GSE43290 data set was downloaded from the Gene Expression Omnibus (GEO) database ([@b19-ol-0-0-8376]). The GSE43290 data set, which includes 47 meningioma samples and 4 normal meningeal samples, was submitted by Tabernero *et al* ([@b20-ol-0-0-8376]). The platform of these microarray data, GPL96 \[HG-U133A\] Affymetrix Human Genome U133A Array, was also downloaded from the GEO database. Using the affy package in R software (version 3.25; [www.r-project.org](www.r-project.org)) ([@b21-ol-0-0-8376]), the obtained raw data were preprocessed, which involved background correction, quartile normalization and probe summarization.

### Extraction of differentially expressed genes (DEGs)

A Student\'s t-test in the Limma package in R software ([@b22-ol-0-0-8376]) was performed to identify the DEGs between the meningioma and normal meningeal (control) samples. All genes that met the following criteria were selected as DEGs: P-value of \<0.05 and \|log~2~(fold change)\| of \>1. A heat map of the extracted DEGs was then created through the gplots package in R, in order to visualize the expression values of genes in the different samples.

### Functional enrichment analysis of DEGs

Following extraction of the DEGs, Gene Ontology (GO) and Kyoto Encyclopedia Genes and Genomes (KEGG) pathway enrichment analyses were conducted. GO analysis is a common bioinformatics method for identifying characteristic biological attributes in large-scale genomic and transcriptomic data ([@b23-ol-0-0-8376]). KEGG is a database for the systematic analysis of genetic functions that links genomic information with higher order functional information ([@b24-ol-0-0-8376]). In the present study, the GO analysis was conducted via the Database for Annotation, Visualization and Integrated Discovery (DAVID; <https://david.ncifcrf.gov>), a web-based tool for systematic functional analysis ([@b25-ol-0-0-8376]). The GO categories selected included 'biological process', 'molecular function' and 'cellular component'. The KEGG pathway analysis of the DEGs was conducted through the ClusterProfiler package in R software. A P-value of \<0.05 was selected as the cut-off criterion.

### Integration of protein-protein interaction (PPI) network and module analysis

PPI network analysis is a method for identifying the associations among various proteins. To acquire further insights into the molecular mechanisms of meningioma, the list of DEGs was entered into the Search Tool for the Retrieval of Interacting Genes (STRING) database, which is an online database designed to evaluate PPI information ([@b26-ol-0-0-8376]). Using this tool, gene-gene interactions with a combined score of \>0.9 were selected to construct the PPI network. Cytoscape software (version 3.4.0) was then used to visualize the obtained PPI network ([@b27-ol-0-0-8376]).

All genes with a connectivity degree (defined as the number of other genes that directly interact with that particular gene) of \>20 were selected as hub genes in the network. The core genes were the most likely to be involved in meningioma and to be potential biomarkers of tumor development and progression. In addition, significant modules of the PPI network were identified using the Molecular Complex Detection (MCODE) Cytoscape plug-in. An MCODE score (indicating the density of nodes) of \>10 and node number of \>10 were selected as the significance threshold criteria. Next, KEGG pathway enrichment analysis of the DEGs in these modules was performed using DAVID aiming to evaluate the genetic functions at the molecular level. A P-value of P\<0.05 was selected as the cut-off criterion for identifying the significant pathways associated with these modules.

Results
=======

### DEGs in meningioma vs. normal meningeal tissues

According to the t-test analysis of the DEGs in the 47 tumor samples compared with the 4 normal meningeal samples, a total of 1,683 DEGs were identified, including 66 upregulated and 1,617 downregulated genes. The heat map of DEG expression is shown in [Fig. 1](#f1-ol-0-0-8376){ref-type="fig"}.

### Enriched GO terms and KEGG pathways of the identified DEGs

In the present study, a total of 649 enriched GO terms and 34 KEGG pathways were identified. The top 30 enriched GO terms of the DEGs according to the P-value threshold (P\<0.05) are shown in [Table I](#tI-ol-0-0-8376){ref-type="table"}. The downregulated genes were significantly associated with 'protein binding', 'cytoplasm', 'extracellular matrix (ECM) organization' and 'cell adhesion', whereas there were no GO terms that were significantly enriched among the upregulated DEGs. The enriched KEGG pathways of the DEGs are shown in [Table II](#tII-ol-0-0-8376){ref-type="table"}. A number of the enriched KEGG pathways were directly associated with cancer, including the 'pathways in cancer' and 'small cell lung cancer' pathways. Furthermore, there was enrichment of certain other pathways that are potentially involved in the development and progression of meningiomas via various biological processes, including the 'AGE-RAGE signaling pathway in diabetic complications', 'PI3K-Akt signaling pathway', 'ECM-receptor interaction' and 'cell adhesion molecules'.

### Module screening from the PPI network

Based on the STRING data, a PPI network of 807 nodes and 2,598 edges was obtained. Nodes with a connectivity degree of \>20 were determined as hub genes ([Table III](#tIII-ol-0-0-8376){ref-type="table"}). Among them, the top five genes according to their connectivity degree were JUN, PIKR1, FOS, AGT and MYC. In addition, according to the connectivity degree of nodes in modules. The top 4 modules with MCODE score of \>10 and node number of \>10 were obtained ([Fig. 2](#f2-ol-0-0-8376){ref-type="fig"}). Functional annotation results revealed that the genes in modules 1, 2 and 4 were mainly associated with the 'chemokine signaling pathway', 'cytokine-cytokine receptor interaction', 'allograft rejection', and 'complement and coagulation cascades', while there were no enriched pathways associated with the DEGs in module 3 ([Table IV](#tIV-ol-0-0-8376){ref-type="table"}).

Discussion
==========

Although previous studies have proposed numerous potential biomarkers associated with the progression and recurrence of meningiomas, the knowledge regarding the molecular mechanisms of meningioma remains relatively limited ([@b13-ol-0-0-8376],[@b16-ol-0-0-8376]--[@b18-ol-0-0-8376]). In the present study, a comprehensive analysis of the gene expression profiles of meningiomas and normal meninges was conducted using a combined bioinformatics approach. A total of 1,683 DEGs (66 upregulated and 1,617 downregulated) were identified. Functional enrichment analysis revealed that these DEGs were mainly involved in ECM organization, cell adhesion, angiogenesis and signal transduction. By constructing a PPI network, a number of hub genes were identified as potential prognostic biomarkers for meningioma.

The gene expression data of 47 meningioma samples and 4 normal controls included in the present study were downloaded from the GEO database with the accession number GSE43290. The 47 tumor samples were composed of 18 diploid tumors, 12 tumors with monosomy 22/del (22q) alone, 4 tumors with del (1p36) alone, and 13 with complex karyotypes associated with del (1p36) and/or del (14q), which are the most frequently altered cytogenetic subgroups of meningiomas in clinical practice ([@b5-ol-0-0-8376],[@b12-ol-0-0-8376]).

The approach used in the current study identified 1,683 DEGs, including 1,617 downregulated and 66 upregulated genes, in meningioma samples as compared with those in normal meninges. These results indicated that gene expression in meningiomas was generally downregulated, which may be attributed to the loss of chromosomal material in meningioma. In addition, GO analysis revealed that the enriched ontological categories among the DEGs mainly included ECM organization, cell adhesion, angiogenesis, signal transduction and negative regulation of cell proliferation. Previous studies have revealed that matrix metalloproteinases (MMPs), which are mediators of invasion and angiogenesis, may serve important roles in the invasion and recurrence of meningioma ([@b28-ol-0-0-8376],[@b29-ol-0-0-8376]). Indeed, cumulative evidence has demonstrated that the contribution of MMPs to tumor progression may be associated with the regulation of cell adhesion, the control of apoptosis via the release of factors associated with cell death or survival, and the proteolysis of the ECM ([@b28-ol-0-0-8376],[@b30-ol-0-0-8376],[@b31-ol-0-0-8376]). Previous studies have demonstrated that the aforementioned GO terms are potentially important events in meningioma development and tumor progression. Furthermore, the KEGG pathway analysis results in the present study revealed that 'ECM-receptor interaction', 'apoptosis' and 'cell adhesion molecules' were among the significantly enriched pathways associated with the DEGs. These findings were consistent with those of a study by Keller *et al* ([@b32-ol-0-0-8376]), which also suggested that 'ECM-receptor interaction' and 'cell adhesion molecules' were significantly dysregulated pathways in meningioma. Therefore, monitoring these biological processes and pathways may aid in the prediction of meningioma development and progression. Furthermore, 31 other enriched pathways were identified in the current study, including 'AGE-RAGE signaling pathway in diabetic complications', 'PI3K-Akt signaling pathway', 'TNF signaling pathway' and 'focal adhesion'. The PI3K-Akt signaling pathway is an intracellular signaling pathway that is important in regulating the cell cycle progression, cell death and cell growth ([@b33-ol-0-0-8376]). Alterations in this pathway are frequently identified as being involved in the development of various types of cancer ([@b34-ol-0-0-8376],[@b35-ol-0-0-8376]).

The top five hub genes identified from a PPI network constructed from the DEGs in the present study were JUN, PIK3R1, FOS, AGT and MYC. Among these hub genes, JUN, a protein-coding gene, exhibited the highest degree of connectivity. JUN is an important component of activator protein 1 (AP-1), a transcription factor that recognizes the specific DNA sequence TGAC/GTCA. This gene modulates numerous biological functions involved in the regulation of cell proliferation, apoptosis and transformation ([@b36-ol-0-0-8376]). The aberrant expression of JUN has been reported in various types of cancer, including glioblastoma and hepatocellular carcinoma ([@b37-ol-0-0-8376],[@b38-ol-0-0-8376]). Furthermore, FOS is a member of the Fos family that encodes leucine zipper proteins that form heterodimers with the JUN family, resulting in the formation of AP-1 ([@b39-ol-0-0-8376]). Thus, this gene also serves important roles in cell proliferation, differentiation and transformation ([@b40-ol-0-0-8376]). Significant associations between FOS and various tumors have also been identified in previous studies ([@b41-ol-0-0-8376],[@b42-ol-0-0-8376]).

PIK3R1, another hub gene identified in the present study, is a critical mediator of insulin sensitivity, and mutation of this gene is associated with insulin resistance, which is an important mechanism involved in human obesity ([@b43-ol-0-0-8376],[@b44-ol-0-0-8376]). McCurdy *et al* ([@b45-ol-0-0-8376]) reported that, in diet-induced obese mice, attenuated PIK3R1 expression was able to prevent insulin resistance. Recently, a large case-control study further suggested that obesity was positively associated with a risk of meningioma ([@b46-ol-0-0-8376]).

The AGT gene, also identified in the current study, is a member of the renin-angiotensin system-associated gene family, which is physiologically important for blood pressure regulation and may be involved in the pathogenesis of hypertension ([@b47-ol-0-0-8376]). Accumulating evidence has demonstrated that increased blood pressure is an independent and additive risk factor for the development of brain tumors, particularly meningiomas ([@b46-ol-0-0-8376]).

Another hub gene, MYC, is located on chromosome 8 and has been closely correlated with cell growth, apoptosis and cellular transformation ([@b48-ol-0-0-8376]). Mutation, overexpression, rearrangement and translocation of this gene have been detected in a variety of tumors, including Burkitt\'s lymphoma, medulloblastoma and hepatocellular carcinoma among others ([@b49-ol-0-0-8376]--[@b51-ol-0-0-8376]).

In the present study, module analysis of the PPI network revealed that the development of meningioma was possibly associated with the chemokine signaling pathway, cytokine-cytokine receptor interaction, allograft rejection, and complement and coagulation cascades. This is consistent with the observations of the study by Keller *et al* ([@b32-ol-0-0-8376]), which analyzed the expression profiles of 24 meningiomas and identified 'cytokine-cytokine receptor interaction' and 'complement pathway and coagulation cascades' as two of the main pathways enriched among the downregulated genes.

In conclusion, by applying a comprehensive bioinformatics analysis of DEGs, the present study identified several hub genes, including JUN, PIK3R1, FOS, AGT and MYC, that may be functionally relevant to the pathogenesis of meningioma. The functional analysis results also revealed a number of potentially significant pathways that may participate in meningioma development and progression, including 'AGE-RAGE signaling pathway in diabetic complications', 'PI3K-Akt signaling pathway', 'ECM-receptor interaction' and 'cell adhesion molecules'. These results provided further insight into the underlying molecular mechanisms of meningioma. Further experimental studies are required to confirm these observations and to determine their potential as molecular targets in the development of novel therapeutic approaches for meningioma.
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###### 

GO analysis of differentially expressed genes associated with meningioma.

  Category           Term                                                                   Count   P-value
  ------------------ ---------------------------------------------------------------------- ------- --------------
  GOTERM_MF_DIRECT   Protein binding                                                        931     5.26×10^−15^
  GOTERM_CC_DIRECT   Cytoplasm                                                              587     1.36×10--13
  GOTERM_BP_DIRECT   Extracellular matrix organization                                      53      1.22×10^−12^
  GOTERM_CC_DIRECT   Cytosol                                                                397     2.33×10--12
  GOTERM_BP_DIRECT   Cell adhesion                                                          91      2.85×10^−12^
  GOTERM_CC_DIRECT   Extracellular exosome                                                  344     8.41×10--12
  GOTERM_CC_DIRECT   Extracellular matrix                                                   61      5.24×10^−10^
  GOTERM_CC_DIRECT   Focal adhesion                                                         73      9.24×10--10
  GOTERM_CC_DIRECT   Z disc                                                                 34      1.06×10^−9^
  GOTERM_BP_DIRECT   Angiogenesis                                                           51      2.10×10-9
  GOTERM_CC_DIRECT   Extracellular space                                                    181     2.87×10^−9^
  GOTERM_BP_DIRECT   Signal transduction                                                    166     5.42×10-9
  GOTERM_BP_DIRECT   Positive regulation of transcription from RNA polymerase II promoter   140     1.15×10^−7^
  GOTERM_CC_DIRECT   Extracellular region                                                   201     1.16×10-7
  GOTERM_MF_DIRECT   Transcription factor binding                                           54      2.02×10^−7^
  GOTERM_CC_DIRECT   Stress fiber                                                           19      3.71×10-7
  GOTERM_BP_DIRECT   Positive regulation of angiogenesis                                    30      3.72×10^−7^
  GOTERM_MF_DIRECT   Identical protein binding                                              109     3.97×10-7
  GOTERM_CC_DIRECT   Integral component of plasma membrane                                  178     4.34×10^−7^
  GOTERM_CC_DIRECT   Cell surface                                                           83      6.11×10-7
  GOTERM_BP_DIRECT   Type I interferon signaling pathway                                    21      6.20×10^−7^
  GOTERM_BP_DIRECT   Negative regulation of cell proliferation                              68      6.72×10-7
  GOTERM_BP_DIRECT   Immune response                                                        71      7.37×10^−7^
  GOTERM_BP_DIRECT   Response to hypoxia                                                    38      7.54×10-7
  GOTERM_CC_DIRECT   Myelin sheath                                                          34      7.94×10^−7^
  GOTERM_CC_DIRECT   Membrane raft                                                          41      1.24×10-6
  GOTERM_CC_DIRECT   Neuron projection                                                      45      1.34×10^−6^
  GOTERM_CC_DIRECT   Actin filament                                                         20      1.73×10-6
  GOTERM_BP_DIRECT   Positive regulation of apoptotic process                               54      2.63×10^−6^
  GOTERM_CC_DIRECT   Proteinaceous extracellular matrix                                     48      3.10×10-6

GO, Gene ontology; MF, molecular function; CC, cellular component; BP, biological process.

###### 

Enriched Kyoto Encyclopedia of Genes and Genomes pathways of differentially expressed genes associated with meningioma.

  Pathway ID   Description                                            Gene count   P-value
  ------------ ------------------------------------------------------ ------------ -------------
  hsa04933     AGE-RAGE signaling pathway in diabetic complications   32           7.86×10^−9^
  hsa04151     PI3K-Akt signaling pathway                             70           3.98×10-8
  hsa04668     TNF signaling pathway                                  32           7.73×10^−8^
  hsa04512     ECM-receptor interaction                               26           1.98×10-7
  hsa04510     Focal adhesion                                         46           3.84×10^−7^
  hsa05410     Hypertrophic cardiomyopathy                            23           1.28×10-5
  hsa04066     HIF-1 signaling pathway                                26           2.21×10^−5^
  hsa04210     Apoptosis                                              32           2.36×10-5
  hsa05146     Amoebiasis                                             25           2.62×10^−5^
  hsa05414     Dilated cardiomyopathy                                 23           5.30×10-5
  hsa05200     Pathways in cancer                                     67           9.01×10^−5^
  hsa05144     Malaria                                                15           1.21×10-4
  hsa05222     Small cell lung cancer                                 21           2.22×10^−4^
  hsa05134     Legionellosis                                          15           4.93×10-4
  hsa05031     Amphetamine addiction                                  17           6.46×10^−4^
  hsa04657     IL-17 signaling pathway                                21           6.90×10-4
  hsa05161     Hepatitis B                                            29           7.24×10^−4^
  hsa04978     Mineral absorption                                     14           8.68×10-4
  hsa04068     FoxO signaling pathway                                 27           8.68×10^−4^
  hsa04010     MAPK signaling pathway                                 44           9.13×10-4
  hsa04064     NF-κB signaling pathway                                21           9.27×10^−4^
  hsa04060     Cytokine-cytokine receptor interaction                 46           9.30×10-4
  hsa05416     Viral myocarditis                                      15           1.10×10^−3^
  hsa05412     Arrhythmogenic right ventricular cardiomyopathy        17           1.29×10-3
  hsa05202     Transcriptional misregulation in cancer                33           1.39×10^−3^
  hsa04514     Cell adhesion molecules                                28           1.40×10-3
  hsa05166     HTLV--I infection                                      43           2.10×10^−3^
  hsa04261     Adrenergic signaling in cardiomyocytes                 28           2.14×10-3
  hsa04022     cGMP-PKG signaling pathway                             30           3.39×10^−3^
  hsa04145     Phagosome                                              28           3.51×10-3
  hsa04610     Complement and coagulation cascades                    17           3.71×10^−3^
  hsa04621     NOD-like receptor signaling pathway                    30           4.06×10-3
  hsa05162     Measles                                                25           4.86×10^−3^
  hsa04921     Oxytocin signaling pathway                             28           5.09×10-3

###### 

Hub genes and their corresponding degree.

  Gene symbol   Degree
  ------------- --------
  JUN           79
  PIK3R1        56
  FOS           53
  AGT           53
  MYC           50
  STAT3         47
  LPAR1         47
  IL8           44
  HSP90AA1      41
  CXCL12        41
  NFKB1         41
  RPS27A        40
  GNAI1         39
  PPBP          37
  CXCR4         35
  HIF1A         33
  NPY           32
  S1PR1         32
  CCL5          31
  SST           30
  IL6           30
  EDN1          30
  EGR1          28
  STAT1         28
  IRF1          28
  CCR7          28
  CXCL2         28
  SSTR2         27
  CCL19         27
  RGS1          27
  RGS4          27
  CXCL9         27
  CXCL1         27
  ADRA2A        27
  HTR1B         27
  HTR1D         27
  CXCL3         27
  C5AR1         27
  MTNR1B        27
  APLNR         27
  P2RY14        27
  HCAR3         27
  ICAM1         25
  CDKN1A        24
  CCND1         23
  PTEN          23
  NOS3          23
  ACTN1         23
  IRF7          23
  KALRN         23
  IRF9          22
  HLA-A         22
  YWHAE         22
  SIRT1         21
  CDH1          21
  GNAQ          21
  ISG15         20

###### 

Enriched Kyoto Encyclopedia of Genes and Genomes pathways of four modules.

  Pathway term                                P-value        Nodes
  ------------------------------------------- -------------- --------------------------------------------------------------------------------
  Module 1                                                   
    Chemokine signaling pathway               1.14×10^−10^   CXCL1, CCR7, PPBP, IL8, GNAI1, CXCR4, CXCL3, CXCL2, CXCL9, CCL19, CCL5, CXCL12
    Cytokine-cytokine receptor interaction    7.02×10-8      CXCL1, CCR7, PPBP, IL8, CXCR4, CXCL3, CXCL2, CXCL9, CCL19, CCL5, CXCL12
    Neuroactive ligand-receptor interaction   7.93×10^−7^    APLNR, HTR1B, SSTR2, C5AR1, S1PR1, P2RY14, ADRA2A, MTNR1B, LPAR1, HTR1D
  Module 2                                                   
    Allograft rejection                       0.0418         HLA-A, HLA-C
    Graft-versus-host disease                 0.0452         HLA-A, HLA-C
    Type I diabetes mellitus                  0.0486         HLA-A, HLA-C
  Module 3                                                   
    No record                                 --             --
  Module 4                                                   
    Complement and coagulation cascades       0.0012         VWF, A2M, F13A1, SERPINE1
    Calcium signaling pathway                 0.0018         AGTR1, EDNRB, GNAQ, PTGFR, HTR2A
    Renal cell carcinoma                      0.0198         VEGFC, TGFB3, PIK3R1
